PCMA Refutes Report from Oncologist Splinter Group on Medicare Part D |
February 02, 2017 | February 2017 Bond Updates |
WASHINGTON, Feb. 1, 2017 /PRNewswire-USNewswire/ -- The Pharmaceutical Care Management Association (PCMA) issued the following statement on a new report by a splinter group of oncologists attacking the use of direct and indirect remuneration (DIR) in the popular Medicare Part D program:... |
View more at: http://www.prnewswire.com/news-releases/pcma-refutes-report-from-oncologist-splinter-group-on-medicare-part-d-300400538.html |
Related News |
|